ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ICVX Company Profile and Key Details

NASDAQ : ICVX

Icosavax, Inc.

$15.31

-0.14-0.91%

At Close 4:00 PM

Not Actively Trading

59.4

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ICVX Stock Price Chart

Stock Price Today

Icosavax, Inc. (ICVX) stock declined over -0.91%, trading at $15.31 on NASDAQ, down from the previous close of $15.45. The stock opened at $15.40, fluctuating between $15.28 and $15.44 in the recent session.

Stock Snapshot

15.45

Prev. Close

15.4

Open

769.04M

Market Cap

50.23M

Number of Shares

15.28

Day Low

15.44

Day High

-6.959090909090909

P/E Ratio

58.34%

Free Float in %

-2.2

EPS (TTM)

4.64

Book Value

-1.47

Cash Flow per Share

8.56M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 29, 2024	15.31	15.31	15.31	15.31	0
Feb 28, 2024	15.31	15.31	15.31	15.31	0
Feb 27, 2024	15.31	15.31	15.31	15.31	0
Feb 26, 2024	15.31	15.31	15.31	15.31	0
Feb 23, 2024	15.31	15.31	15.31	15.31	0
Feb 22, 2024	15.31	15.31	15.31	15.31	0
Feb 21, 2024	15.31	15.31	15.31	15.31	0
Feb 20, 2024	15.31	15.31	15.31	15.31	0
Feb 16, 2024	15.40	15.44	15.28	15.31	9.32M
Feb 15, 2024	15.40	15.47	15.20	15.45	5.67M
Feb 14, 2024	15.55	15.58	15.34	15.35	1.2M
Feb 13, 2024	15.40	15.55	15.35	15.43	628.11K
Feb 12, 2024	15.37	15.47	15.34	15.41	353.34K
Feb 09, 2024	15.30	15.43	15.30	15.36	448.81K
Feb 08, 2024	15.27	15.37	15.27	15.31	303.35K
Feb 07, 2024	15.22	15.30	15.20	15.25	553.46K
Feb 06, 2024	15.25	15.26	15.20	15.24	283.02K
Feb 05, 2024	15.22	15.29	15.19	15.25	415.19K
Feb 02, 2024	15.22	15.32	15.19	15.24	274.05K
Feb 01, 2024	15.32	15.32	15.18	15.21	886.68K

Contact Details

Seattle, WA 98102

United States

Website: https://icosavax.comContact: 206 737 0085

About Company

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Frequently Asked Questions

What is the current Icosavax, Inc. (ICVX) stock price?

Icosavax, Inc. (NASDAQ: ICVX) stock price is $15.31 in the last trading session. During the trading session, ICVX stock reached the peak price of $15.44 while $15.28 was the lowest point it dropped to. The percentage change in ICVX stock occurred in the recent session was -0.91% while the dollar amount for the price change in ICVX stock was -$0.14.

ICVX's industry and sector of operation?

The NASDAQ listed ICVX is part of Biotechnology industry that operates in the broader Healthcare sector. Icosavax, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ICVX?

Mr. Neil King Ph.D.
Chair of Scientific Advisory Board & Co-Founder
Dr. Cassia Cearley Ph.D.
Treasurer & Chief Bus. Officer
Mr. Adam K. Simpson
Pres, Chief Executive Officer, Co-Founder & Director
Ms. Lori Stewart
Senior Vice President of People & Culture
Ms. Elizabeth Bekiroglu
Gen. Counsel & Corporation Sec.
Dr. Ami Shah Brown MPH, Ph.D.
Senior Vice President of Regulatory Affairs
Dr. Charles E. Richardson Ph.D.
Senior Vice President of Technical Operations
Mr. Niranjan Kanesa-thasan M.D.
Chief Medical Officer
Ms. Jennifer Raymond
Senior Vice President of Technical Operations
Mr. Thomas Joseph Russo C.F.A.
Chief Financial Officer
Mr. Douglas A. Holtzman M.P.H., Ph.D.
Chief Scientific Officer

How ICVX did perform over past 52-week?

ICVX's closing price is 222.32% higher than its 52-week low of $4.75 where as its distance from 52-week high of $16.11 is -4.94%.

How many employees does ICVX have?

Number of ICVX employees currently stands at 60.

Link for ICVX official website?

Official Website of ICVX is: https://icosavax.com

How do I contact ICVX?

ICVX could be contacted at phone 206 737 0085 and can also be accessed through its website. ICVX operates from 1616 Eastlake Avenue East, Seattle, WA 98102, United States.

How many shares of ICVX are traded daily?

ICVX stock volume for the day was 8.56M shares. The average number of ICVX shares traded daily for last 3 months was 1.05M.

What is the market cap of ICVX currently?

The market value of ICVX currently stands at $769.04M with its latest stock price at $15.31 and 50.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	60
Beta	1.28
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology